More Than Weight: Treating Obesity as Part of a Comprehensive Care Approach to Cardiometabolic Disease
June 25 from 5:30 am — 7:30 am PDT
Supported By: Novo Nordisk, Inc.
Treating obesity is not just about managing weight. Obesity impacts multiple organ systems, and effective management of obesity as a chronic disease requires treating comorbid conditions. This symposium takes a unique approach to education. Following 3 short didactic presentations to set the stage, learners will evaluate interesting cases, presented on video from experts in other specialties. These cases will explore the treatment of obesity beyond weight loss, including how to manage comorbidities, with a particular focus on nonalcoholic fatty liver disease, cardiovascular disease, and osteoarthritis.
The audience will have an opportunity to assess treatment approaches for each case based on evidence from expert presentations and faculty discussions. These case discussions will revolve around a biopsychosocial model incorporating the recognition of comorbidities, psychological aspects, and practical pharmacotherapy approaches to care.
The activity is intended for endocrinologists and endocrinology HCPs who are interested in treating and managing obesity as part of a comprehensive cardiometabolic disease management plan.
Upon completion of this activity, participants should be able to:
- Describe the biological mechanisms of appetite and weight control that are dysregulated in people with obesity
- Discuss the link between obesity and its comorbidities, including cardiometabolic diseases
- Evaluate the latest clinical data on available and emerging antiobesity medications
- Identify appropriate treatment plans for individuals with obesity and comorbid conditions
5:30 – 6:00 am Registration and Breakfast
6:00 – 6:05 am Welcome and Introduction
Domenica M Rubino, MD—Program Chair
6:05– 6:15 am Refocusing Obesity Care to Improve Long-Term Health Outcomes
Jaime Almandoz, MD, MBA, FTOS, MRCPI
6:15 – 7:15 am Case-Based Panel Discussions
- Case 1, Cardiology Conundrum
- Case 2, Hepatology History
- Case 3, Osteoarthritis Obstacle
Faculty Panel, moderated by Domenica M Rubino, MD
7:15 – 7:30 am Summary and Close
CME Accreditation and Credit Designation Statements
The Institute for Medical and Nursing Education, Inc. (IMNE), is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
IMNE designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is designed for healthcare providers for educational purposes. Information and opinions offered by the faculty/presenters represent their own viewpoints. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information.
While IMNE makes every effort to have accurate information presented, no warranty, expressed or implied, is offered. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Jaime Almandoz MD, MBA, FTOS, MRCPI
UT Southwestern Medical Center
Department of Internal Medicine, Division of Endocrinology
UTSW Clinical Research Unit
Center for Translational Medicine
Domenica M Rubino MD
Washington Center for Weight Management and Research
MD—Program Chair Director
Sean Wharton MD, FRCPC, PharmD
University and York University
Adjunct Professor McMaster
PharmD Internal Medicine Specialist
Diplomate of the American Board of Obesity Medicine (ABOM)
Burlington, Ontario, Canada